莫沙比利和多潘立酮治疗消化性溃疡对比观察
| 第1页 |
参见附件(1311KB，1页)。
摘要：目的：对莫沙比利和多潘立酮治疗胃溃疡的临床疗效进行比较，评价两药的疗效和安全性。方法：106例消化性溃疡且幽门螺杆菌感染阳性患者随机分成治疗组49例和对照组57例。治疗组予以莫沙必利治疗；对照组予多潘立酮治疗。结果：治疗组疗效优于对照组，P<0.05，并可以降低并发症的发生。结论:莫沙比利联合抑酸剂治疗消化性溃疡能达到较高的治愈率，两组对比，治疗组起效更快，能更早缓解症状。
关键词：多潘立酮;莫沙比利;消化性溃疡Abstract:Objective: To compare the clinical effect between Mosapride and Domperidone on peptic ulcer, and estimate their curative effect and safety.Methods: 106 cases of peptic ulcer patients with H. pylori infection were divided into 2 groups randomly. The patients in treatment group were given Mosapride, and the cases in control group were given Domperidone. Results: The curative effect of the treatment group was better than the control group (P<0.05). Meanwhile Mosapride can reduce complications obviously. Conclusion: Mosapride combined with antacid can achieve a higher cure rate of peptic ulcer. Comparing the two groups, Mosapride could get better curative effect and relieve symptoms sooner.
Key word: Domperidone; Mosapride;peptic ulcer
【中图分类号】R864 ......
您现在查看是摘要介绍页，详见PDF附件(1311KB，1页)。